Skip navigation

Brain tumour research

The brain is a soft spongy mass of nerve cells and supporting tissue.Around 4,500 people are diagnosed with brain tumours, or cancer of the central nervous system, in the UK every year.

Brain tumours are often hard to treat, so research in this area is vital. For children, the survival rates have doubled since the 1960s.

Cancer Research UK supports a broad programme of research into brain tumours. We want to understand their biology and improve diagnosis and treatment.

We have made great progress in the design and development of drugs. For example, we funded research that led to the development of temozolomide, a drug that is used to treat people with some types of brain tumour. It can be taken orally, which means patients don’t have to attend lots of hospital appointments.

You can find out more about brain tumours on our CancerHelp website.

Below are some of the highlights of our brain tumour research portfolio.

Biomarkers

Dr Steven Pollard Dr Steven Pollard

Wellcome Trust Centre for Stem Cell Research

University of Cambridge, Cambridge

Studying stem cells in brain tumours

Cancer genes

Dr Stefan Meyer Dr Stefan Meyer

Department of Paediatric Oncology

Christie Hospital NHS Trust, Manchester

Learning more about childhood cancers

Clinical trials

Prof David Walker Prof David Walker

School of Human Development

University of Nottingham, Nottingham

Testing treatments for childhood brain cancer

Radiobiology

Prof Richard Houlston Prof Richard Houlston

Molecular and Population Genetics Team

The Institute of Cancer Research, Sutton

Genes and cancer

Radiotherapy

Prof Michele Saunders Prof Michele Saunders

Department of Oncology

Royal Free & University College Medical School, London

Improving radiotherapy for cancer treatment

Stem cells

Dr Steven Pollard Dr Steven Pollard

Wellcome Trust Centre for Stem Cell Research

University of Cambridge, Cambridge

Studying stem cells in brain tumours